Treatment of Alcohol Withdrawal Syndrome: Phenobarbital vs CIWA-Ar Protocol
Author(s) -
William P. Tidwell,
Tonya L. Thomas,
Jonathon D. Pouliot,
Angelo E. Caico,
Angus J. Webber
Publication year - 2018
Publication title -
american journal of critical care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.592
H-Index - 81
eISSN - 1937-710X
pISSN - 1062-3264
DOI - 10.4037/ajcc2018745
Subject(s) - medicine , alcohol withdrawal syndrome , phenobarbital , intensive care unit , mechanical ventilation , anesthesia , benzodiazepine , incidence (geometry) , emergency medicine , alcohol , biochemistry , chemistry , physics , receptor , optics
Benzodiazepine-based therapy for alcohol withdrawal is associated with agitation and respiratory depression. Treatment can be complicated by a need for adjunctive therapy to control these symptoms and in patients requiring mechanical ventilation. Strong evidence for the effectiveness of alternative treatment modalities is lacking, despite the availability of promising pharmacological agents such as phenobarbital.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom